Prostaglandin E2 is activated by airway injury and regulates fibroblast cytoskeletal dynamics
Authors:
- Vlad C. SandulacheVSVlad C. Sandulache
- Mark BarsicMBMark Barsic
- Patricia A. HebdaPHPatricia A. Hebda
- 14 May 2009
- journal article
- molecular biology
- Published by Wiley in The Laryngoscope
- Vol. 119 (7) , 1365-1373
Abstract
Objectives/Hypothesis: To characterize the activation of cyclooxygenase (COX)‐2/prostaglandin (PG) E2 signaling during airway mucosal repair and its subsequent role during the wound healing process.Study Design: Prospective animal study.Methods: The subglottis was approached via cricothyroidotomy. Sham airways were closed, and wounded airways were subjected to laser injury and closed. Subglottic tissue was harvested at 12 hours, 24 hours, 48 hours, and 72 hours postinjury. Secretions were collected preoperatively and at time of sacrifice. Inflammatory gene expression was analyzed using quantitative reverse transcriptase polymerase chain reaction. Subglottic/tracheal explants were exposed to exogenous IL‐1β in the presence or absence of COX inhibitors. Explant‐produced PGE2 levels were assayed using enzyme linked immunoassays. Human airway fibroblast migration and collagen contraction were assayed in the presence or absence of prostaglandin E2.Results: Laser injury triggers a rapid, dose‐dependent increase in mucosal IL‐1β and COX‐2 gene expression, with an anatomical distribution proportional to the distance from the site of injury. Gene upregulation correlates with dose‐dependent increases in PGE2 mucosal secretion levels. Ex vivo analysis indicates IL‐1β is responsible for the activation of the COX‐2 / PGE2 pathway. Prostaglandin E2 differentially inhibits airway fibroblast migration and contraction in a specific, dose‐dependent manner.Conclusions: PGE2 is activated during mucosal inflammation and acts to decrease fibroplastic activity in the mucosal wound bed. During subglottic stenosis (SGS) development, the levels of PGE2 generated in response to injury may be insufficient to blunt the intrinsically fibroplastic phenotype of SGS fibroblasts, resulting in excessive scarring. Laryngoscope, 2009Keywords
Funding Information
- National Institutes of Health Grant (#R01 DC007437)
- Children's Hospital of Pittsburgh
This publication has 24 references indexed in Scilit:
- Acute and Chronic Changes in the Subglottis Induced by Graded Carbon Dioxide Laser Injury in the Rabbit AirwayJAMA Otolaryngology–Head & Neck Surgery, 2008
- Prostaglandin E2 is a major soluble factor produced by stromal cells for preventing inflammatory cytokine production from dendritic cellsInternational Immunology, 2008
- Fetal Dermal Fibroblasts Retain a Hyperactive Migratory and Contractile Phenotype Under 2-and 3-Dimensional Constraints Compared to Normal Adult FibroblastsTissue Engineering, 2007
- PTGER1 and PTGER2 receptors mediate regulation of progesterone synthesis and type 1 11β-hydroxysteroid dehydrogenase activity by prostaglandin E2 in human granulosa–lutein cellsJournal of Endocrinology, 2007
- Prostaglandin E2 inhibition of keloid fibroblast migration, contraction, and transforming growth factor (TGF)‐β1–induced collagen synthesisWound Repair and Regeneration, 2007
- Prostaglandin E2 differentially modulates human fetal and adult dermal fibroblast migration and contraction: implication for wound healingWound Repair and Regeneration, 2006
- COX-1 and COX-2 contribute differentially to the LPS-induced release of PGE2 and TxA2 in liver macrophagesProstaglandins & Other Lipid Mediators, 2006
- 15-Hydroxyprostaglandin dehydrogenase, a COX-2 oncogene antagonist, is a TGF-β-induced suppressor of human gastrointestinal cancersProceedings of the National Academy of Sciences, 2004
- The Impact of Cyclooxygenase-2 Mediated Inflammation on Scarless Fetal Wound HealingThe American Journal of Pathology, 2004
- Cultured lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis have a diminished capacity to synthesize prostaglandin E2 and to express cyclooxygenase-2.Journal of Clinical Investigation, 1995